how much weight loss is effective on nonalcoholic fatty liver disease?

conclusions this intervention offers a practical approach for treatment of patients with nafld with diet therapy. patients and methods forty four patients with nafld received a diet including a 500 to 1000 kcal per day intake reduction as30% fat, 15% protein, and 55% carbohydrate for six months. anthropometric parameters, alanine aminotransferase (alt), aspartate aminotransferase (ast), gamma glutamyl transferase (ggt), lipid profile, malondialdehyde (mda), tnf-α, il-6, ck18-m30 were measured at baseline and at the end of the study. at the end of follow up, patients were classified as adherent or nonadherent to treatment according to a weight loss of ≥ 5%, or < 5% of initial body weight, respectively. background nonalcoholic fatty liver disease (nafld) is the most common liver disease worldwide with no specific treatment. weight loss is the most effective therapeutic strategy in its management; however, there is no consensus on its specifics. thus, this study was conducted to evaluate the effects of weight loss on liver enzymes, markers of inflammation, oxidative stress and ck18-m30 (cytokeratin 18) as a biomarker of hepatocellular apoptosis. results twenty five patients were classified as adherent group and nineteen as nonadherent group (9.7% vs. 1.9% total body weight loss after 6 months, respectively). after 6 months, changes in adherent and nonadherent groups were as follows: reduction in body weight from 93.7 ± 15.8 kg to 84.2 ± 13.4 kg vs. 94 ± 16.6 kg to 92.2 ± 16.2 kg (p < 0.05), bmi from 32.7 ± 3.9 to 29.5 ± 3.2 vs.31.8 ± 5.4 to 31.1 ± 5.3 (p < 0.001), and waist circumference from 105.1 ± 12.6 cm to 97.4 ± 9.8 cm vs.106.8 ± 14.2 cm to 103.7 ± 14 cm (p < 0.001), respectively. diastolic blood pressure was significantly decreased in adherent group (from 80.2 ± 5.1 mmhg to 76.9 ± 5 mmhg; p < 0.001). also, total cholesterol, ldl, triglyceride, alt, ast, ggt and ck18-m30 levels were significantly decreased in the adherent group compared to nonadherent group (p < 0.05). objectives to study the effect of weight reduction diet as an exclusive treatment for nafld.